(Q36259797)

13 August 2017

1 reference

4 November 2019

Cisplatin and its analogues in the treatment of advanced breast cancer: a review (English)

1 reference

13 August 2017

1 reference

4 November 2019

1 reference

4 November 2019

Smith IE

1

1 reference

13 August 2017

Talbot DC

series ordinal

2

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 June 1992

5 references

British Journal of Cancer

13 August 2017

13 March 2019

3 April 2019

17 June 2019

4 November 2019

5 references

13 August 2017

13 March 2019

3 April 2019

17 June 2019

4 November 2019

65

1 reference

13 August 2017

6

1 reference

13 August 2017

787-793

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1992.169

13 August 2017

0 references

cites work

High-dose cis-diamminedichloro-platinum therapy in patients with advanced breast cancer: pharmacokinetics, toxicity, and therapeutic efficacy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977765

Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977765

Phase II study of iproplatin in metastatic breast carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977765

Phase II study of iproplatin in advanced ovarian carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977765

Iproplatin and carboplatin induced toxicities: overview of phase II clinical trial conducted by the EORTC Early Clinical Trials Cooperative Group (ECTG).

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977765

Clinical trial of iproplatin (cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum IV, CHIP) in patients with advanced breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977765

Carboplatin: a very active new cisplatin analog in the treatment of small cell lung cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977765

High dose carboplatin in the treatment of lung cancer and mesothelioma: a phase I dose escalation study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977765

A phase II trial of iproplatin (CHIP) in previously treated advanced breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977765

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977765

Cisplatin in the management of breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977765

Carboplatin, etoposide, and ifosfamide as intensive chemotherapy for small-cell lung cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977765

Phase II study of carboplatin in advanced breast cancer: preliminary results

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977765

Phase II study of cis-dichlorodiammineplatinum(II) in advanced breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977765

Ovarian trials at the Royal Marsden.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977765

A 5-day regimen of cyclophosphamide, adriamycin, platinum (CAP) in refractory breast cancer.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977765

Cisplatin as first-line therapy for metastatic breast cancer

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977765

Cisplatin and etoposide: an effective treatment for refractory breast carcinoma.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977765

cis-platinum-based alternating non-cross-resistant chemotherapy as a first-line treatment in metastatic breast cancer. A phase II study.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977765

A phase I-II study of cyclophosphamide, thiotepa, and carboplatin with autologous bone marrow transplantation in solid tumor patients

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977765

CAP (cyclophosphamide, adriamycin, platinum) vs CMFVP (cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisolone) combination chemotherapy in untreated metastatic breast cancer. A preliminary report of a controlled clinical study.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977765

Cisplatin in the treatment of metastatic breast carcinoma: A prospective randomized trial of two dosage schedules

22 September 2018

1 reference

12 December 2020

Phase II clinical trial of cis-dichlorodiammine platinum (cis-DDP) for antitumorigenic activity in previously untreated patients with metastatic breast cancer

1 reference

12 December 2020

Cisplatin and etoposide as first-line chemotherapy for metastatic breast carcinoma: a prospective randomized trial of the Italian Oncology Group for Clinical Research

1 reference

12 December 2020

Platinol (CDDP) and continuous intravenous infusion 5-fluorouracil in refractory stage IV breast cancer: a phase II study

1 reference

12 December 2020

Cyclophosphamide, Adriamycin, and cis-Platinum (CAP) in Metastatic and Locally Advanced Breast Cancer

1 reference

12 December 2020

High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer

1 reference

12 December 2020

Combination of cyclophosphamide, adriamycin and platinum (CAP) versus 5-fluorouracil, adriamycin and cyclophosphamide (FAC) as primary treatment in metastatic breast cancer: results of a prospective randomized study

1 reference

12 December 2020

Chemotherapy with cis-Platin, Doxorubicin, and Cyclophosphamide (CAP) in Patients with Metastatic Breast Cancer

1 reference

12 December 2020

A phase II study of cis-diamminedichloroplatinum II for advanced breast cancer. Two dose schedules

1 reference

12 December 2020

A phase III clinical trial comparing the combination cyclophosphamide, adriamycin, cisplatin with cyclophosphamide, 5-fluorouracil, prednisone in patients with advanced breast cancer

1 reference

12 December 2020

Phase I trial of escalating doses of cisplatin in hypertonic saline

1 reference

12 December 2020

Cyclophosphamide, epirubicin and cisplatin (CEP) in advanced breast cancer: preliminary results

1 reference

12 December 2020

Platinum and etoposide in chemotherapy refractory metastatic breast cancer. A phase II trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.).

1 reference

12 December 2020

Phase II trial of carboplatin in advanced breast carcinoma: a Cancer and Leukemia Group B Study

1 reference

12 December 2020

Cisplatin plus vindesine in advanced breast cancer: a phase II trial of the EORTC Breast Cancer Cooperative Group

1 reference

12 December 2020

Evaluation of the continuous infusion of etoposide plus cisplatin in metastatic breast cancer. A collaborative North Central Cancer Treatment Group/Mayo Clinic phase II study

1 reference

12 December 2020

CAP (cyclophosphamide, adriamycin, cisplatinum) in the treatment of advanced breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1992.169

1 reference

13 August 2017

1 reference

13 August 2017

PubMed publication ID

1616849

1 reference